Compare CRWS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRWS | BRNS |
|---|---|---|
| Founded | 1957 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 55.9M |
| IPO Year | N/A | 2021 |
| Metric | CRWS | BRNS |
|---|---|---|
| Price | $2.64 | $0.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 84.4K | ★ 103.6K |
| Earning Date | 11-12-2025 | 11-07-2025 |
| Dividend Yield | ★ 12.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $85,751,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $2.35 | $0.64 |
| 52 Week High | $4.59 | $2.92 |
| Indicator | CRWS | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 35.03 | 39.99 |
| Support Level | $2.72 | $0.68 |
| Resistance Level | $2.84 | $0.78 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 11.15 | 32.61 |
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.